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Understanding the mechanisms by which signal transduction pathways mediate changes
in RNA abundance requires the examination of the fate of RNA from its transcription
to its degradation. Evidence suggests that RNA abundance is partly regulated by post-
transcriptional mechanisms affecting RNA decay and this in turn is modulated by some
of the same signaling pathways that control transcription. Furthermore, the translation of
mRNA is a key regulatory step that is inﬂuenced by signal transduction. These processes
are regulated, in part, by RNA-binding proteins (RBPs) which bind to sequence-speciﬁc
RNA elements. The function of RBPs is controlled and co-ordinated by phosphorylation.
Based on the current literaturewe hypothesize that RBPsmay be a point of convergence for
the activity of different kinases such as phosphoinositide-3-kinase and mitogen-activated
protein kinase which regulate RBP localization and function.
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INTRODUCTION
The response of cells to environmental stimuli frequently involves
changes in gene expression. This may be controlled at multiple
levels including the production of new RNA by transcription.
Post-transcriptional regulation at the RNA level includes nuclear
RNA processing (frequently a co-transcriptional process), as well
as RNA export, decay, localization, and translation. These pro-
cesses are integratedwith changes in protein stability and function.
Signaling pathways are a major mechanism for co-ordination of
these distinct mechanisms (Schoenberg and Maquat, 2012).
Substantial evidence obtained over two decades has highlighted
the importance of mRNA stability in gene regulation (Cheadle
et al., 2005; Keene, 2007; Anderson, 2008; Hao and Baltimore,
2009). The half-life of different mRNAs can vary from 15 min to
more than 24 h depending on the activation status of a cell, for
example, the half-life for interleukin-2 (IL-2) mRNA is 17 min in
non-stimulated T cells but upon activation with anti-CD3/CD28
the half-life for IL-2 mRNA is increased to 232 min (Ragha-
van et al., 2002, 2004; Yang et al., 2003). The mRNA half-lives in
bacteria (Bernstein et al., 2002) and yeast (Wang et al., 2002) are
mostly shorter in comparison to mammalian cells. The increased
mRNA half-life correlates with increasing organismal complexity
and a tendency for 3′ untranslated regions (UTR) within mRNA
to become longer in more complex species (Mazumder et al.,
2003; Dinger et al., 2011). Thus, post-transcriptional regulation of
mRNA may be a more prevalent amongst complex multicellular
organisms.
The difference in mRNA half-lives can lead to signiﬁcant
changes in the abundance of mRNA (Ross, 1995). This was illus-
trated in genome-wide studies which have shown that up to 50%
of altered mRNA abundance in lymphocytes is due to the regu-
lation of mRNA stability (Lam et al., 2001; Cheadle et al., 2005).
The stability of mRNA is regulated by distinct sequences present
in the coding and UTR of mRNA (Caput et al., 1986; Shaw and
Kamen, 1986; Schoenberg and Maquat, 2012). Conservation of
these sequences within the UTR region among different species
further emphasizes their regulatory role.
The fate of RNA can be regulated by the interplay between
sequences within the RNA (cis-acting) and trans-acting factors
present in the nucleus and cytoplasm (Keene, 2007; Anderson,
2010; Elkon et al., 2010). Trans-acting factors such as non-coding
RNA (Rinn and Chang, 2012),microRNA (Fabian and Sonenberg,
2012), and RNA-binding proteins (RBPs) have been reported to
regulate mRNA stability and translation. Translation can also be
regulated through control of the length of the poly(A) tail in the
cytoplasm (Weill et al., 2012). The class of trans-acting factors we
will focus on in this review are the RBPs. The function of RBPs can
be controlled by different signaling pathways and several excellent
reviews covering the detailed regulation of RBPs in response to
stress pathways have been published (Eberhardt et al., 2007; Doller
et al., 2008; Sandler and Stoecklin, 2008; Kim et al., 2010). Here we
will discuss the function of selected RBPs at the molecular level
and how they are being controlled by phosphoinositide-3-kinase
(PI3K) and mitogen-activated protein kinases (MAPK) signaling.
RNA-BINDING PROTEINS
It has been estimated that approximately 1000 RBPs are encoded
in the mammalian genome (Keene, 2007; Araujo et al., 2012; Baltz
et al., 2012; Castello et al., 2012). These play important roles in
splicing, nuclear export, mRNA stability, localization, and trans-
lation. RBPs exert their function by physically interacting with
RNA and can do so in a sequence-speciﬁc manner. Amongst the
well-characterized sequences that bind RBPs are the adenine- and
uridine-rich elements (ARE). RBPs that bind toARE includeKSRP
as well as TTP (TIS11) and its homologs TIS11b (also called
BRF-1; butyrate response factor-1), and TIS11d (BRF-2). These
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have been shown to promote ARE-dependent mRNA decay but
may also affect translation. HuR and its close relatives have also
been suggested to promote mRNA stability and to regulate trans-
lation (Srikantan and Gorospe, 2012; Yiakouvaki et al., 2012). The
domain structures of these RBPs are depicted in Figure 1.
CONTROL OF RBP FUNCTION BY SIGNAL TRANSDUCTION
PATHWAYS
Diverse stimuli (such as chemical and environmental media-
tors, reviewed in Eberhardt et al., 2007) induce signaling cascades
which control RBP function by means of protein phosphoryla-
tion. However the details of how these signaling pathways control
the abundance and RNA-binding properties of RBPs at molecular
level are only beginning to be understood. Amongst the signal-
ing kinases discussed below and summarized in Table 1 are PI3K,
PKB (protein kinase B),mTOR (mammalian target of rapamycin),
and p38MAPK. Experimentally determined phosphorylation sites
on the RBPs we will focus on are depicted in Figure 1. A more
extensive list derived from phospho-proteomics studies is given in
Table 2.
THE PI3K PATHWAY
The PI3K pathway plays an important role in controlling
cell growth, differentiation, survival, chemotaxis, and meta-
bolism. The activation of PI3K stimulates the generation of
phosphatidylinositol 3,4,5 trisphosphate at the cell membrane,
which mediates the recruitment of PKB (also known as AKT)
and phosphoinositide-dependent kinase 1 (PDK1). PKB is then
activated following phosphorylation by PDK1 at Thr308. Mam-
malian target of rapamycin complex 2 (mTORC2) phosphorylates
PKB at hydrophobic motif (Ser473; Jacinto et al., 2006; Sarbassov
et al., 2006; Facchinetti et al., 2008). PKB,which has three isoforms
encoded by different genes, is involved in regulating cell prolifer-
ation and survival (Pearce et al., 2010). Genetic alterations in the
PI3K pathway, such as mutations in catalytic subunits and loss
of the negative regulator PTEN have been found in cancers (Kok
et al., 2009). PI3K also regulates immunity and inﬂammation by
controlling the recruitment and activation of immune cells. Thus,
PI3K is an important signal integrator in maintaining immune
homeostasis.
An early report implicated PI3K in the regulation of the stability
of IL-3mRNAbyTIS11/TTP but did not identify phosphorylation
siteswithinTTP (Ming et al., 2001). Subsequent studies usingmass
spectroscopy identiﬁedover 30 phosphorylation sites onTTP (Cao
et al., 2006). Both Ser60 and Ser113 in human TTP are predicted
to be PKB phosphorylation sites (Cao et al., 2007) but this has not
been experimentally conﬁrmed.
Following activation of the PI3K pathway the phosphoryla-
tion of TIS11b by PKB at Ser90, Ser92, and Ser203 facilitates its
binding with 14-3-3. This sequesters TIS11b in the cytoplasm and
FIGURE 1 | Schematic view of domains and phosphorylation sites
in KSRP, HuR andTis11b proteins. (A) KH domains and nuclear
localization signals are represented in light gray and black colors
respectively. The amino acid numbers are depicted on top of protein
domain structure. Proline/glycine-rich and glutamine-rich domains on
N-terminal and C-teriminal end respectively are marked. (B) Hinge region
(containing nucleocytoplasmic sequence and nuclear localization signal,
NLS); RNA recognition motifs (RRM) and their corresponding amino
acid positions are depicted. (C) Activation domains on N- and C-terminal
ends, NLS, nuclear export sequence (NES), and RBD (RNA-binding domain)
are shown. The experimentally determined phosphorylation sites on
RBPs are given colors in following manner, red: PKB phosphorylation
sites, blue: p38 phosphorylation sites, yellow: MK2 phosphorylation
sites.
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Table 1 | Representative list of signaling kinases regulating RBP function.
RBP Kinase Phosphosite/
inhibitor/siRNA
Type of cell Target gene Fate of RBP or its target
gene function
Reference
TIS11 Protor-2 siRNA Jurkat TNF-α, COX-2,
GM-CSF, IL-3
Regulate RBP function Holmes et al. (2012)
TIS11 MK2 siRNA HPMECs ICAM-1 and IL-8 Target gene mRNA stability Shi et al. (2012)
TIS11 MK2 Ser52, Ser178 3T3 Inhibition of mRNA decay
property, RBP stability
Chrestensen et al. (2004)
TIS11b PKB Ser92, Ser203 HT1080 and MEF Inhibition of mRNA decay
property, RBP stability
Schmidlin et al. (2004)
TIS11b MK2 Ser54, Ser92,
Ser203
HT1080 GM-CSF Inhibition of mRNA decay
property
Maitra et al. (2008)
HuR mTOR siRNA RIE-1 Ornithine
decarboxylase
Target gene mRNA stability Origanti et al. (2012)
HuR MK2 Inhibitor 184B5/HER COX-2 Target gene mRNA stability Subbaramaiah et al. (2003)
TIA1 mTOR Inhibitor HeLa 5′ terminal
oligopyrimidine
tracts
Translation repressor Damgaard and Lykke-Andersen
(2011)
TIAR mTOR Inhibitor HeLa 5′ terminal
oligopyrimidine
tracts (5′TOP)
Translation repressor Damgaard and Lykke-Andersen
(2011)
KSRP PKB Ser193 Alpha-T3-1 β-catenin Inhibition of mRNA decay
property
Gherzi et al. (2006)
NF90 PKB Ser647 Jurkat IL-2 Stabilizing mRNA Pei et al. (2008)
hnRNP F mTOR Inhibitor HEK293 controls
proliferation
Goh et al. (2010)
CELF1 PKB Ser28 Myoblasts CcnD1 Salisbury et al. (2008)
Nucleolin PI3K Inhibitor Endothelial cell line KLF2 Up regulation of KLF2 Huddleson et al. (2006)
IMP2 mTOR Ser162/164 Human RD IGF2 Regulate translation of IGF2 Dai et al. (2011)
YB1 PKB Ser99 CEF Regulate translation capacity
of YB1
Bader and Vogt (2008)
Table 1 shows type of kinase and/or its phosphorylation site on RBP function over its target gene in a speciﬁc cell. In studies where phosphorylation site is not
reported, authors used either inhibitor or siRNA against studied kinase to analyse its role on RBP function.
inhibits its ability to promotemRNAdecay (Schmidlin et al., 2004;
Benjamin et al., 2006). Phosphorylation of these sites appears to
increase the stability of the TIS11b protein which is consistent
with a shorter half-life/increased degradation of TIS11b protein in
PKBα knockout mouse embryo-derived ﬁbroblasts (MEFs; Ben-
jamin et al., 2006). Mutagenesis of Ser90, Ser92, and Ser203 in
TIS11b uncoupled it from regulation by PKB and the mutated
protein, which retained the ability to promote RNA decay, could
no longer associate with 14-3-3 (Benjamin et al., 2006).
KSRP mediates mRNA destabilization by binding to AREs in
target mRNAs. Phosphorylation of KSRP at Ser193 by PKB facil-
itates its binding to 14-3-3 which inhibits its interaction with
the RNA decay machinery (in this case the exosome; Gherzi
et al., 2006). In this way, KSRP is prevented from promoting
the degradation of β-catenin mRNA (Gherzi et al., 2006). Phos-
phorylation at Ser193 creates a binding site for 14-3-3ζ in the
N-terminal KH domain of KSRP (Diaz-Moreno et al., 2009)
which, upon interaction with KSRP, promotes its nuclear local-
ization. Thus, the availability of KSRP in cytoplasm and its ability
to mediate mRNA decay is limited by phosphorylation. Interest-
ingly, phosphorylation at Ser193 redirects the function of KSRP
to become a regulator of the maturation of miRNA (Trabucchi
et al., 2009). In C2C12 myoblasts PI3K-dependent phosphoryla-
tion of KSRP enhanced its ability to accelerate myogenic miRNA
processing while attenuating its ability to promote myogenic
mRNAdecay. Thus, duringmyogenesis, KSRP appears to function
as a dynamic switch controlling RNA regulated by PI3K (Briata
et al., 2012).
The importance of the PI3K pathway in controlling mRNA
decaywas further illustrated by a recent studywhich demonstrated
that approximately 20 out of 50 transcripts regulated by PI3Kwere
affected at the level of mRNA stability (Graham et al., 2010). Using
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Table 2 | Phosphorylation sites on RBP from phospho-proteomic studies.
RBP Kinase Phosphorylation site Type of cell Reference
TIS11 MK2 Ser52 3T3 Wang et al. (2008)
TIS11 CAMK2 Ser52 CD8T Navarro et al. (2011)
TIS11 PKB Ser248 CD8T Navarro et al. (2011)
TIS11 PKA Ser197 HEK-293 Cao et al. (2006)
TIS11 GSK3 Ser218 HEK-293 Cao et al. (2006)
TIS11 ERK Ser228 HEK-293 Cao et al. (2006)
TIS11b PKA/PKB Ser54/92 CD8T Hsu et al. (2011);
Navarro et al. (2011)
TIS11b mTOR Ser334 MEF Hsu et al. (2011)
TIS11d PKB Ser98 3T3 Wang et al. (2008)
TIS11d PKA/PKB Ser28/98 CD8T Navarro et al. (2011)
TIS11d mTOR Ser57/73/416/464 MEF Hsu et al. (2011)
KSRP mTOR Ser182, Ser185 MEF Yu et al. (2011)
KSRP PKA Ser481 CD8T Navarro et al. (2011)
Nucleolin mTOR Ser28/34/40/41/145/157/616/
189/403/212/460,Thr121
MEF Yu et al. (2011)
Roquin ERK/MAPK Ser770 CD8T Navarro et al. (2011)
Roquin mTOR Ser531/535 MEF Hsu et al. (2011)
hnRNPk CDK2 Ser284 CD8T Navarro et al. (2011)
hnRNPu CK1 Ser187 CD8T Navarro et al. (2011)
hnRNPu CAMK2 Ser247 CD8T Navarro et al. (2011)
hnRNPF mTOR Ser63 MEF Hsu et al. (2011)
hnRNPA3 mTOR Ser356/359/367 MEF Hsu et al. (2011)
hnRNPA3 CK1 Ser359 CD8T Navarro et al. (2011)
hnRNPA3 PKA Ser357 CD8T Navarro et al. (2011)
hnRNPAb PKA Ser260 CD8T Navarro et al. (2011)
AUF1 mTOR Ser82/83, Thr177 MEF Hsu et al. (2011)
hnRNPA2B1 mTOR Ser245/247/266/272,
Tyr254
MEF Hsu et al. (2011)
hnRNPK mTOR Ser284/379 MEF Hsu et al. (2011)
hnRNPC mTOR Ser229/232/241/268/306/313 MEF Hsu et al. (2011)
hnRNPUL1 mTOR Ser513 MEF Hsu et al. (2011)
hnRNPUL1 CAMK2 Ser195 CD8T Navarro et al. (2011)
hnRNPA1 mTOR Ser6/257 MEF Hsu et al. (2011)
hnRNPA1 CDK1 Ser6 CD8T Navarro et al. (2011)
hnRNPH2 mTOR Ser104 MEF Hsu et al. (2011)
HuR mTOR Ser202 MEF Yu et al. (2011)
IMP2 mTOR Ser102 MEF Yu et al. (2011)
IMP2 mTOR Ser160/161/163 MEF Hsu et al. (2011)
The phosphorylation sites on RBPs for respective kinases in a speciﬁc cell are obtained from published phospho-proteomic studies. In Yu et al. (2011)), mTOR
phosphorylation sites on RBP in MEFs are derived using inhibitors rapamycin and KU-0063794 against mTOR in a SILAC experiment. Similarly in Hsu et al. (2011),
mTOR regulated phosphosites on RBPs in MEFs were veriﬁed using Torin1 (mTOR) inhibitor in an iTRAQ experiment. By employing SILAC technology, Navarro et al.
(2011) identiﬁed phosphorylation sites on different RBPs for the respective kinases in TCR stimulated CD8T cells. Wang et al. (2008) identiﬁed phosphorylation sites
on RBPs in 3T3 cells using iTRAQ.
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siRNA knockdown experiments TIS11b and KSRP were shown to
be involved in stabilization of themRNAs of down-regulated genes
(Graham et al., 2010). Interestingly Graham et al., 2010) observed
no effect onmRNA stability by RBPs such asAUF1 andHuRwhich
are not known to be controlled by PI3K signaling, suggesting a key
role of PI3K pathway in maintaining mRNA stability via TIS11b
and KSRP.
MAMMALIAN TARGET OF RAPAMYCIN
The mTOR is a kinase component of signaling complexes which
play very important roles in immune cell function (Powell et al.,
2012). The mTORC1 complex can be activated in a PI3K-
dependent or independent manner and is highly susceptible to
inhibition by rapamycin. By contrast, mTORC2 which phospho-
rylates PKB Ser473 and contributes to its activation is much less
sensitive to rapamycin (Jacinto et al., 2006; Sarbassov et al., 2006;
Facchinetti et al., 2008). mTOR can also be activated in a PI3K-
independent manner by spleen tyrosine kinase (SYK), as reported
in follicular lymphoma cells (Leseux et al., 2006). In addition to
SYK, the Erk pathway can also activate mTOR (Shaw and Cantley,
2006). Thus, mTOR activated in a PI3K-dependent or indepen-
dent manner exerts effector functions via a number of targets
including PKB (Powell et al., 2012).
In a phospho-proteomic study theBlenisGroup reported Ser182
and Ser185 as phosphorylation sites on KSRP for mTOR. These
ﬁndings were veriﬁed by treating MEFs with the mTOR inhibitors
rapamycin and KU-0063794 (Table 2; Yu et al., 2011). The same
phosphorylation sites in KSRP were predicted by PHOSIDA
(www.phosida.com; the post-translational modiﬁcation database
which provides information on the sites of phosphorylation, N-
glycosylation, and acetylation across nine different species; Gnad
et al., 2007; Gnad et al., 2011). However Ser185 of KSRP has
also been predicted to be a casein kinase 1 (CK1) phosphory-
lation site and the function of this phosphorylation is presently
unknown.
The Blenis group also reported HuR Ser202 as a phosphoryla-
tion site for mTOR and this ﬁnding was substantiated using the
mTOR inhibitors rapamycin and KU-0063794 in MEFs (Table 2;
Yu et al., 2011). However, limited evidence exists for the func-
tional regulation of HuR by mTOR as it has not yet been reported
whether or not mTOR regulates HuR localization and function.
Previously the Gorospe group had reported Ser202 as a target for
cyclin-dependent kinase 1 (Cdk1; Kim et al., 2008). Phosphory-
lation of HuR by Cdk1 promoted its movement into the nucleus
whereHuRappeared tobe associatedwith 14-3-3proteins. Amod-
iﬁed HuR protein with a non-phosphorylatable serine to alanine
mutation resided predominantly in the cytoplasm. Unphosphory-
latedHuRbound poorly to 14-3-3, which increased the availability
of HuR for stabilizing its target mRNAs (Kim et al., 2008). Thus,
the function of HuR is modulated by Cdk1 during the cell cycle
(Blethrow et al., 2008; Kim et al., 2008). In another very recent
report CDK5 phosphorylation of HuR at Ser202 has been shown
to regulate its function in cell cycle progression (Filippova et al.,
2012). HuR regulates ornithine decarboxylase (ODC) mRNA sta-
bility (Nowotarski and Shantz, 2010) and the binding of HuR
to the ODC transcript is decreased when mTORC1 signaling
is inhibited using rapamycin, an mTORC1 inhibitor (Origanti
et al., 2012). The mTOR mediated phosphorylation at Ser202 on
HuR might be one mechanism through which mTOR regulates
proliferation.
Protor2, a component of mTORC2 kinase has been shown to
bind to TTP in Jurkat cells following treatment with carbonyl
cyanide 4-(triﬂuoromethoxy) phenylhydrazone, an uncoupler
of mitochondrial oxidative phosphorylation. The interaction
between TTP and Protor2 was suggested to be necessary for
enhancing TTP-mediated turnover of mRNAs such as IL-3,
GM-CSF, COX-2, and TNF (Holmes et al., 2012). The siRNA
knockdown of protor2 inhibited the localization of TTP to
mRNA processing bodies (P-bodies), the sites where mRNA
decay enzymes are concentrated (Parker and Sheth, 2007). Very
recently mTOR has been reported to regulate iron homeostasis by
modulating transferrin receptor 1 (TfR1) stability via TTP (Bayeva
et al., 2012).
THE P38 MAPK PATHWAY
Mitogen-activated protein kinases are major regulatory hubs
where inﬂammation and stress responses are regulated. Three
major MAPK pathways are p38, JNK, and ERK. We discuss below
the ﬁndings implicating p38 and its substrate MAPK activated
protein kinase 2 (MK2) in regulating RBP activity.
The p38 pathway via MK2 regulates the mRNA decay prop-
erty and the mRNA and protein expression of TTP (Dean et al.,
2001; Tchen et al., 2004; Brook et al., 2006; Hitti et al., 2006).
MK2 phosphorylates mouse TTP at Ser52 and Ser178 which stabi-
lizes TTP protein (Brook et al., 2006). Upon dephosphorylation
of these sites, TTP moves from the cytoplasm to the nucleus
and undergoes degradation (Brook et al., 2006). MK2-mediated
phosphorylation of TTP does not affect its binding to target
mRNA, but inhibits the ability of TTP to recruit deadenylases
to target mRNA for their degradation in cytoplasm (Carballo
et al., 2001; Stoecklin et al., 2004; Clement et al., 2011). Further
investigation of this demonstrated that carbon catabolite repres-
sor protein 4-associated factor-1 (CAF1) was the major source
of deadenylase activity responsible for TTP-directed deadenyla-
tion (Marchese et al., 2010). MK2 phosphorylation reduced the
ability of TTP to promote deadenylation by inhibiting the recruit-
ment of CAF1 deadenylase independently of 14-3-3. The Stoecklin
group demonstrated that Not1, a component of carbon catabo-
lite repressor protein 4 (Ccr4)-negative on TATA (NOT) complex,
associates with TTP and is required for the decay of ARE-mRNAs
(Sandler et al., 2011). Subsequently it has been reported that
TTP regulates the translation of TNF mRNA at the endoplas-
mic reticulum (Tiedje et al., 2012). Phosphorylation of TTP by
MK2 weakens its ability to bind to TNF mRNA and allowed
HuR-binding to TNF mRNA which promoted its translation.
Conﬂicting data exists on the ability of phospho-TTP to bind
its target mRNA (Clement et al., 2011; Tiedje et al., 2012) The
former group found that phosphorylation did not alter TTP
binding to its target mRNA but the latter group found that phos-
phorylation reduced the afﬁnity of TTP binding to its target
mRNA.
TIS11b is also regulated by MK2. The phosphorylation of
TIS11b at Ser54, Ser92, and Ser203 by MK2 inhibits the ability
of TIS11b to promote ARE-mediated mRNA decay (Maitra et al.,
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2008). The phosphorylation-dependent inhibitory effects of MK2
on TIS11b do not seem to alter its ability to bind RNA or its
association with mRNA decay enzymes. Furthermore, the MK2-
mediated effects on TIS11b were independent of PKB (Maitra
et al., 2008).
Several studies indicate that the function of HuR is regulated
by the p38 pathway. The abundance of COX-2 mRNA is con-
trolled by the p38-dependent regulation of the binding of HuR
to the COX-2 3′ UTR (Subbaramaiah et al., 2003). In neuronal
cell line p38 activation following treatment with anisomycin pro-
motes the cytoplasmic accumulation of HuR where it interacts
with and stabilizes the survival motor neuron (SMN) transcript
(Farooq et al., 2009). In mouse splenic T cells, LFA-1 engagement
activates p38 which promotes HuR translocation and stabilization
of IFN-γ and TNF mRNA (Ramgolam et al., 2010). In none of
these studies was it established whether HuR was directly phos-
phorylated by p38 or MK2. However, an independent study has
reported that phosphorylation of HuR at Thr118 by p38 promotes
its localization to the cytoplasm where it stabilizes p21 mRNA
during the DNA damage response (Lafarga et al., 2009). HuR was
found to be phosphorylated at Thr118 a site previously identiﬁed
to be phosphorylated by Chk2 (Abdelmohsen et al., 2007). HuR
regulated translation of TNFmRNA at the endoplasmic reticulum
appeared to be mediated by the effects of the p38 pathway on TTP
(Tiedje et al., 2012) and no evidence was found for p38-mediated
phosphorylation of HuR. It was suggested that Thr118 was instead
phosphorylated by Chk2 as a consequence of the over-expression
system being used (Tiedje et al., 2012).
The p38 pathway also regulates KSRP. During C2C12 mus-
cle cell differentiation the stability of p21, myogenin, and MyoD
mRNA is regulated by p38-mediated phosphorylation of KSRP
(Briata et al., 2005). p38 phosphorylates KSRP at Thr692 which
renders KSRP unable to bind to ARE-containing transcripts thus
promoting their stabilization. However, this phosphorylation
event does not alter the ability of KSRP to interact with the mRNA
degradation machinery (Briata et al., 2005). To our knowledge it
has not yet been reported whether or not p38 regulates KSRP
function in microRNA maturation.
FIGURE 2 | Convergence of signaling on RBP and its function. (A) In
non-activated cells, RBPs (TIS11b and KSRP) are active in promoting mRNA
decay of ARE-containing transcripts. (B) Upon activation, PKB and MK2
phosphorylate TIS11b at Ser92 and Ser203 and subsequently TIS11b is
prevented in mediating ARE-mediated mRNA decay. Similarly, but not at
same phosphorylation sites, KSRP is phosphorylated at Ser193 andThr692 by
PKB and p38 respectively. These phosphorylation events inhibit KSRP in
mediating ARE-mediated mRNA decay. Transcription factors upon activation
by signals from kinases drive transcription which is illustrated in the Figure 2.
The phosphorylation sites are shown in star shape cartoons.
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ARE RBPs A POINT OF CONVERGENCE FOR PI3K AND p38
SIGNALING?
In NIH 3T3 ﬁbroblasts, the stability of TPA induced IL-3 mRNA
is regulated by the p38 and PI3K pathways (Ming et al., 2001). The
latter mediates its effects independently of p38 suggesting that p38
and PI3K pathways control IL-3mRNA turnover by parallelmech-
anisms. Stabilization of IL-3 mRNA mediated by either of these
two pathways is antagonized by TTP and this effect can be over-
come by HuR when it is in collaboration with p38 but not with
PI3K (Ming et al., 2001). This suggests that signaling pathways
activated upon stimulation lead either to activation of stabiliz-
ing RBP (HuR) or inactivation of destabilizing RBP (TTP) thus
preventing the degradation of transcripts (Ming et al., 2001). Fur-
thermore, another study reported that in U87 glioblastoma cells,
the regulation of cyclin D1 and c-Myc mRNA stability by TTP is
controlled by p38 in a PKB-dependentmanner (Marderosian et al.,
2006), implying interdependent roles for p38 and PKB. Data from
phospho-proteomic (Cao et al., 2006, 2007; Navarro et al., 2011)
and in vitro (Chrestensen et al., 2004) studies suggest that MK2
and PKB phosphorylate TTP at Ser52/178 and Ser248 respectively
(Table 2).
Both PKB and MK2 target the same phosphorylation sites on
TIS11b (Ser92 and Ser203) and inhibit its mRNA decay activity
(Benjamin et al., 2006;Maitra et al., 2008). ThemRNAdecay prop-
erty of KSRP is also regulated by PKB and p38 (Briata et al., 2005;
Gherzi et al., 2006), but in this instance the kinases do not use the
same phosphorylation sites.
HuR provides a further example of a point of convergence. In
this case the circumstances under which the mTOR would affect
HuR have not been studied but the phosphorylation site (Ser202)
has been shown to regulate the function of the protein. Simi-
larly, p38-mediated phosphorylation of HuR at Thr118 targets a
site previously shown to be targeted by Chk2 (Abdelmohsen et al.,
2007). It is clear that multiple different kinases converge on HuR
to regulate its function (Figure 2).
FEEDBACK BETWEEN RBPs AND PI3K mTOR PATHWAY
Current literature suggests that kinases control the function of
RBPs, however RBPs have also been reported to regulate the
expression of kinases suggesting a role forRBPs in feedback control
over kinase expression. For example, the 68 kDa Src substrate
associated during mitosis (Sam68) is an RBP reported to regu-
late alternative splicing of mTOR (Huot et al., 2012). In Sam68
knockout cells, intron ﬁve is retained in the mTOR transcript
introducing a premature termination codon, which results in
an unstable mRNA and subsequently reduced protein levels of
mTOR. Consequently, the effector pathways of mTOR responsi-
ble for adipogenesis are deregulated in thesemice, leading to a lean
phenotype (Huot et al., 2012). Sam68 is also reported to associate
with PI3K in insulin receptor signaling (Sanchez-Margalet and
Najib, 2001) and this association may regulate the RNA-binding
function of Sam68 (Taylor et al., 1995). Based on this information
it is possible that PI3K is regulating RBP function via its down-
stream kinases and regulating the abundance of its downstream
kinases (mTOR) via possible activation of Sam68. Conserved
ARE elements in 3′ UTR of p38α, PKBα, PKBγ but not p38β,
p38γ, and PKBβ, suggest that these proteins might be targets for
regulation of ARE-mediated mRNA stability by RBPs (Gruber
et al., 2011).
CONCLUSION
Gene expression is controlled at the post-transcriptional level by
RBPs. However, regulation of the effector function of RBPs on
RNA decay and translation is controlled by signals from protein
kinases. These effects include inhibition of function by uncou-
pling from the RNA decay machinery and in some instances
reassignment of function. Kinase-dependent relocation of RBP
into different compartments of the cell seems to be a com-
mon theme amongst structurally diverse RBPs. RBPs represent
a class of proteins upon which signaling by the PI3K and p38
pathways converge. Existing literature on this might indicate a
potential redundancy of kinases phosphorylating the same serine
or threonine amino acid in different cellular functions. A fuller
understanding of the interplay between kinases, RBPs and tar-
get RNAs may provide important new insights into the dynamic
regulation of gene expression.
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